Acute Myelocytic Leukemia

Search Trials
Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Mar 20, 2009
First Changed:
Mar 20, 2009
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Decitabine 15 mg/m2 i.v.
A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia.
Status:
Active, not recruiting
Last Changed:
Dec 17, 2021
First Changed:
Dec 8, 2014
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
gilteritinibIdarubicinCytarabine
Velcaflagida in Relapsed or Refractary Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Feb 28, 2013
First Changed:
Apr 3, 2008
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Bortezomib
A Study of CG-806 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status:
Recruiting
Last Changed:
Jul 21, 2021
First Changed:
Jul 20, 2020
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
CG-806
Actinium-225-Lintuzumab in Patients With Acute Myeloid Leukemia
Status:
Withdrawn
Last Changed:
Mar 8, 2019
First Changed:
Oct 15, 2018
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Ac-Lintuzumab

Connect. Empower. Inspire.